New Healixia logo
Search
Search

Our Board

The Executive Board manages Healixia, making sure our values, motivations and your expectations are met. 

The Board is currently composed of 2 representatives per domain (the 4 founding domains: Regulatory Affairs, Medical Affairs, Clinical Research, Early Development) and, starting next term (2026-2028), 2 additional seats for young professionals (up to 35 years old) active in any of these domains. A President and Vice-President are appointed among the Board Members.

Have a look at the team! 

Healixia president

  • Erik Present

    Erik Present

    (Medical Affairs)
    Benelux Medical Director

Healixia vice-president

  • Marian Coquel

    Marian Coquel

    (Regulatory Affairs)
    Managing Director Regulatory Affairs & Quality

Healixia board members

  • Annabelle Bruyndonckx

    Annabelle Bruyndonckx

    (Regulatory Affairs)
    Partner Healthcare Life Sciences
  • Dimitri Buytaert

    Dimitri Buytaert

    (Clinical Research)
    Senior Manager Clinical Operations
  • Jan de Hoon

    Jan de Hoon

    (Early Development)
    Professor in Pharmacology and Head of Department of the Center for Clinical Pharmacology
  • Veronique Lins

    Veronique Lins

    (Clinical Research)
    E2E Integration Director Johnson & Johnson
  • Sylvie Rottey

    Sylvie Rottey

    (Early Development)
    Professor, Medical Oncologist & Clinical Pharmacologist, Head of Drug Research Unit Ghent and Head of Departement Medical Oncology
  • Sarah Tavernier

    Sarah Tavernier

    (Medical Affairs)
    Medical Advisor Hematology

Our Board